Stampa

W06 Ricerca farmaco

A randomized Phase III study to compare arsenic trioxide (ATO) combined to ATRA and idarubicin versus standard ATRA and anthracycLine-based chemotherapy (AIDA regimen) for patients with newLy diagnosed, high-risk acute prOmyelocytic leukemia
2015-001151-68
Università di Dresda
TUD-APOLLO-064
13-06-2016
13-06-2016
0.00
0.00
0.00

Pincipal investigators

Ematologia di Ravenna
Eliana Zuffa
Ematologia di Rimini
Anna Maria Mianulli